A study to investigate the effect of AZD0780 tablets in combination with rosuvastatin tablets on low density lipoprotein cholesterol levels (LDL-C) in adult participants with dyslipidaemia

Trial Identifier:	AZ-RU-00013
Sponsor:	AstraZeneca
Start Date:	October 2025
Primary Completion Date:	September 2026
Study Completion Date:	September 2026
Condition:	Heart, Blood & Circulatory - Other

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service